Skip to main content
. 2016 Jun 16;2016(6):CD011889. doi: 10.1002/14651858.CD011889.pub2

Pini 2008.

Methods R, DB, PC, cross‐over trial
3 consecutive episodes treated with 3 different medications
Participants Episodic TTH (IHS), 4‐14 days/month, no nausea, vomiting, photo‐ or phonophobia. Previous response to OTC medication. Daily consumption ≥ 2 cups of coffee
Excl: contraindications to study medication; migraine or post‐traumatic headache; overuse of analgesics; significant medical history
n = 99 (93 for safety, 81 for efficacy)
M 40, F 59
Mean age 35 years (SD 10, range 19‐64 years)
Baseline PI: 59% mod, 16% mild, 25% severe
Interventions Paracetamol 1000 mg + caffeine 130 mg
Naproxen sodium 550 mg
Placebo
Rescue medication (ibuprofen 600 mg) to be taken at 2 h if necessary
Outcomes PI: 4‐point scale over 4 h
PR: 5‐point scale over 4 h
Rescue medication
Patient global evaluation: 5‐point scale at 4 h
Use of rescue medication
AEs
Notes Oxford Quality Score: R2, DB2, W1
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomisation code"
Allocation concealment (selection bias) Low risk "Assigned in sequential order of entry"; "access to the randomization code was strictly controlled and treatment assignment remained unknown to all parties until formal database lock"
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk "double‐dummy method"; "identical boxes"; "matched supplies, identical in colour, size, shape and taste"
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk "double‐dummy method"; "identical boxes"; "matched supplies, identical in colour, size, shape and taste"
Incomplete outcome data (attrition bias) 
 All outcomes High risk ITT analysis included only those taking all 3 interventions. LOCF imputation. 10 participants did not provide pain relief data, with no reason given
Size Unclear risk 50‐200 participants per treatment arm (94‐98)